[Radioactive iodine (I-131) therapy]
- PMID: 10483265
[Radioactive iodine (I-131) therapy]
Abstract
It was in 1942 that radioactive iodine, I-131, was applied to therapy of Graves' disease. Recently, this therapy is popular in Japan because the maximum therapeutic dose of I-131 for outpatients was estimated. The feature of I-131 therapy in patients with hyperthyroidism due to Graves' disease is as follow as; 1. The most effective method of I-131 therapy is performed under the state of hyperthyroidism. 2. The symptom of hyperthyroidism will be disappeared from 1 month after the therapy gradually. 3. Transient hypothyroidism may be appeared 3-4 months after the therapy. 4. Hypothyroidism after I-131 therapy will be difficult to avoid in their future. I-131 therapy should be undertaken in the patients with uncontrolled hyperthyroidism by medication of anti-thyroid drug.
Similar articles
-
Long-term follow-up study of radioiodine treatment of hyperthyroidism.Clin Endocrinol (Oxf). 2004 Nov;61(5):641-8. doi: 10.1111/j.1365-2265.2004.02152.x. Clin Endocrinol (Oxf). 2004. PMID: 15521969
-
Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.J Assoc Physicians India. 2005 Jul;53:603-6. J Assoc Physicians India. 2005. PMID: 16190128
-
Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.QJM. 1995 Mar;88(3):175-80. QJM. 1995. PMID: 7767667
-
Radioactive iodine therapy in Graves' hyperthyroidism.Natl Med J India. 2000 Sep-Oct;13(5):246-51. Natl Med J India. 2000. PMID: 11190053 Review.
-
Radioiodine treatment of juvenile Graves disease.Exp Clin Endocrinol Diabetes. 1997;105 Suppl 4:61-5. doi: 10.1055/s-0029-1211936. Exp Clin Endocrinol Diabetes. 1997. PMID: 9439919 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources